Scarica l'app Stockscreener
0.18
4.76%
-0.009
Pre-mercato:
.19
0.01
+5.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$0.189
Aprire:
$0.198
Volume 24 ore:
1.38M
Relative Volume:
0.72
Capitalizzazione di mercato:
$8.31M
Reddito:
$7.33M
Utile/perdita netta:
$-21.20M
Rapporto P/E:
-0.1969
EPS:
-0.9143
Flusso di cassa netto:
$-12.68M
1 W Prestazione:
-32.05%
1M Prestazione:
-53.42%
6M Prestazione:
-43.82%
1 anno Prestazione:
-76.59%
Intervallo 1D:
$0.1754
$0.20
Intervallo di 1 settimana:
$0.1754
$0.2858
Portata 52W:
$0.1754
$0.9349
Prophase Labs Inc Stock (PRPH) Company Profile
Nome
Prophase Labs Inc
Settore
Industria
Telefono
(215) 345-0919
Indirizzo
711 STEWART AVE, SUITE 200, NEW YORK, PA
Confronta PRPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.18 | 7.85M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-13 | Downgrade | Dawson James | Buy → Neutral |
| 2021-01-20 | Iniziato | Dawson James | Buy |
Prophase Labs Inc Borsa (PRPH) Ultime notizie
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2025 Earnings Call Transcript - MSN
ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances - MSN
Is ProPhase Labs Inc. stock vulnerable to regulatory risksForecast Cut & Advanced Technical Analysis Signals - newser.com
Reversal indicators forming on ProPhase Labs Inc. stock2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
ProPhase Labs Reports Q3 Loss Amid Strategic Shifts - TipRanks
Earnings call transcript: ProPhase Labs Q3 2025 posts unexpected EPS loss - Investing.com Nigeria
ProPhase Labs’ Earnings Call: Challenges and Opportunities - The Globe and Mail
What data driven models say about ProPhase Labs Inc.’s future - newser.com
ProPhase Labs Q3 2025 Earnings Call Transcript - MarketBeat
[10-Q] ProPhase Labs, Inc. Quarterly Earnings Report | PRPH SEC FilingForm 10-Q - Stock Titan
ProPhase Labs in talks for strategic initiative, cites undervalued assets By Investing.com - Investing.com Nigeria
ProPhase Labs, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PRPH) 2025-11-19 - Seeking Alpha
Prophase Labs Unveils Strategic Initiatives and Partnerships - MSN
ProPhase Labs, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025 - MarketScreener
ProPhase Labs earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
ProPhase Labs reported results for the third quarter ended September 30, 2025, and will hold a virtual conference call today at 2pm ET. - MarketScreener
ProPhase Labs (PRPH) Explores Strategic M&A Opportunities - GuruFocus
ProPhase Labs (PRPH) Q3 Revenue Decline but Future Prospects Bri - GuruFocus
[8-K] ProPhase Labs, Inc. Reports Material Event | PRPH SEC FilingForm 8-K - Stock Titan
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. - The Manila Times
ProPhase Labs in talks for strategic initiative, cites undervalued assets - Investing.com
ProPhase Labs Explores Strategic Initiatives to Unlock Company Value Amidst Key Developments in Crown Medical and BE-Smart™ Commercialization - Quiver Quantitative
ProPhase Labs Reported Results for the Third Quarter Ended - GlobeNewswire
ProPhase Labs (NASDAQ: PRPH) Targets $50M Crown Medical Recoveries to Fund BE-Smart - Stock Titan
How ProPhase Labs Inc. stock reacts to job market dataTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
A Peek at ProPhase Labs's Future Earnings - Benzinga
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 - The Manila Times
Starwood Property Trust (NYSE: STWD) Plans $500M 2028 Notes for Green, Social Uses - Stock Titan
Why analysts upgrade ProPhase Labs Inc. stockJuly 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
ProPhase Labs reminds shareholders of upcoming special meeting By Investing.com - Investing.com Nigeria
ProPhase Labs Inc. stock chart pattern explainedJuly 2025 Recap & Daily Price Action Insights - newser.com
ProPhase Labs (PRPH) Announces Special Meeting to Shape Future S - GuruFocus
ProPhase Labs reminds shareholders of upcoming special meeting - Investing.com
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals - The Manila Times
ProPhase Labs urges shareholders to vote by November 23 on proxy proposals - MarketScreener
Prophase Labs Urges Shareholders To Vote By November 23 On Proxy Proposals - TradingView
ProPhase Labs (NASDAQ: PRPH) urges shareholder votes by Nov. 23 for Nov. 24 meeting - Stock Titan
Using data tools to time your ProPhase Labs Inc. exitMarket Sentiment Review & Weekly Hot Stock Watchlists - newser.com
Can ProPhase Labs Inc. stock beat analyst upgradesJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Can machine learning forecast ProPhase Labs Inc. recovery2025 Investor Takeaways & Verified Momentum Stock Alerts - newser.com
ProPhase Labs Delays Q3 Filing Amid Reorganization - MSN
What moving averages say about ProPhase Labs Inc.July 2025 Volume & Expert Approved Momentum Ideas - newser.com
Prophase Labs Inc Azioni (PRPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.35%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):